Cell Culture Media Market by Type, End-User Application and


Dublin, March 30, 2022 (GLOBE NEWSWIRE) — The “Cell Culture Media Market by Type (serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Conventional, Specialty), Application (Biopharmaceutical (mAbs, vaccine), diagnostics, tissue engineering), end-user (pharmaceutical, biotech) – The Global Forecast to 2026 report” has been added to from ResearchAndMarkets.com offer.

The global cell culture media market is expected to reach USD 10.3 billion by 2026, from USD 4.9 billion in 2021, growing at a CAGR of 16.0% between 2021 and 2026.

The growth of this market is mainly driven by increasing awareness of the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), cell research funding, stem cell research growth, launch new cell culture media. by market players and the growing importance given to personalized medicine. On the other hand, the high cost of cell biology research is hampering the growth of this market.

Serum-free media segment accounted for the highest growth rate in the cell culture media market, by type, during the forecast period

In 2020, the serum-free media segment accounted for the largest market share. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth and productivity, better control of physiological reactivity, and reduced risk of contamination with adventitious agents transmitted through the bloodstream. serum in cell culture.

Thermo Fisher Scientific, Inc. (USA), Merck KGaA (Germany), Danaher Corporation (USA), Sartorius AG (Germany), Corning Incorporated (USA), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (USA), MiltenyiBiotec (Germany), HiMedia Laboratories Pvt. ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (USA), Cell Applications, Inc. (USA) are some of the key players operating in the cell culture media market.

Asia-Pacific: The fastest growing region in the cell culture media market

The cell culture media market is segmented into North America, Europe, Asia-Pacific, Latin America (LATAM), and Middle East and Africa (MEA). The Asia-Pacific market is expected to register the highest CAGR of 17.5% during the forecast period. The growing geriatric population, favorable regulatory guidelines, government support for the production of cell culture-based vaccines, low manufacturing costs, and the growing focus of global market players on emerging Asian economies are the major drivers. contributing to the cell culture media market growth in Asia-Pacific.

Main topics covered:

1. Introduction

2 Research methodology

3 Executive summary

4 premium previews
4.1 Cell Culture Media Market Overview
4.2 North America Cell Culture Media Market, by Type and Country (2020)
4.3 Cell Culture Media Market Share, by Application, 2021 vs. 2026
4.4 Cell Culture Media Market, by End User, 2020 (Million USD)
4.5 Cell Culture Media Market: Geographic Growth Opportunities

5 Market Overview
5.1 Presentation
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D spending in pharmaceutical companies
5.2.1.2 Emerging cell culture technologies for cell-based vaccines
5.2.1.3 Increase in demand for monoclonal antibodies
5.2.1.4 Growth of stem cell research
5.2.1.5 New Product Launch of Cell Culture Media by Market Players
5.2.1.6 Growing focus on personalized medicine
5.2.2 Constraints
5.2.2.1 Expensive cell biology research products
5.2.2.2 Ethical concerns about cell biology research
5.2.3 Opportunities
5.2.3.1 Advances in 3D cell culture
5.2.3.2 Increased Incidence of Infectious Diseases and Pandemic Outbreaks
5.2.3.3 Emerging markets
5.2.4 Challenges
5.2.4.1 Survival of small players and new entrants
5.3 Ranges/scenarios
5.4 Trends/disruptions affecting customer business
5.5 Impact of COVID-19 Outbreak on Cell Culture Media Market
5.6 Price Analysis
5.7 Patent Analysis
5.8 Value chain analysis
5.9 Supply Chain Analysis
5.10 Cell Culture Media Market Ecosystem Analysis
5.11 Porter’s Five Forces Analysis
5.12 Regulatory analysis
5.12.1 United States
5.12.2 Europe

6 Cell Culture Media Market, by Type
6.1 Presentation
6.1.1 Serum-free media
6.1.1.1 Cho Media
6.1.1.1.1 Growing Adoption of Cho Media in Biopharmaceutical Companies to Drive the Growth of this Market Segment
6.1.1.2 Media Hek 293
6.1.1.2.1 The benefits of Hek 293 cell lines are expected to drive the growth of this market segment
6.1.1.3 Media Bhk
6.1.1.3.1 Bhk media have many applications in the production of recombinant proteins
6.1.1.4 Vero Cell Media
6.1.1.4.1 Growing role of Vero cells in viral vaccine research to drive the growth of this market segment
6.1.1.5 Serum-free stem cell media
6.1.1.5.1 Availability of funding for stem cell research driving the growth of this market segment
6.1.1.6 Media for insect cells
6.1.1.6.1 Growing adoption of insect cell media for heterologous protein expression driving the growth of this market segment
6.1.1.7 Car T-cell
6.1.1.7.1 Growing demand for adoptive T cell therapy to drive the growth of this market segment
6.1.1.8 Other serum-free media
6.1.2 Conventional media and salts
6.1.2.1 Wide usage of conventional media and salts in all types of cell culture applications to drive the growth of this market segment
6.1.3 Stem cell culture media
6.1.3.1 Increase collaborations between universities and pharmaceutical and biotechnology companies for stem cell research to drive the growth of this market segment
6.1.4 Chemically defined media (Cd)
6.1.4.1 Ability of CD media to increase reproducibility to drive the growth of this market segment
6.1.5 Specialized media
6.1.5.1 The ability of primary cells to proliferate in specialized media is expected to fuel the growth of this market segment
6.1.6 Other cell culture media

7 Cell Culture Media Market, by Application
7.1 Presentation
7.2 Biopharmaceutical production
7.2.1 Production of monoclonal antibodies
7.2.1.1 Growing demand for monoclonal antibody production is fueling the growth of this market segment
7.2.2 Vaccine production
7.2.2.1 Growing government support for vaccine production to drive the growth of this market segment
7.2.3 Other Therapeutic Protein Production
7.3 Diagnosis
7.3.1 Rising Incidence of Infectious Diseases to Drive the Growth of this Market Segment
7.4 Screening and drug development
7.4.1 Adoption of cell-based assays in drug discovery will drive the growth of this market segment
7.5 Tissue engineering and regenerative medicine
7.5.1 Cell and gene therapy
7.5.1.1 Increasing adoption of cell and gene therapies for treating patients to fuel the growth of this market
7.5.2 Other Tissue Engineering and Regenerative Medicine Applications
7.6 Other applications

8 Cell Culture Media Market, By End User
8.1 Presentation
8.2 Pharmaceutical and biotechnology companies
8.2.1 Rising research expenditure by pharmaceutical and biotechnology companies will drive the growth of this segment
8.3 Hospitals and diagnostic laboratories
8.3.1 Increase applications of cell culture media in disease diagnosis to drive the growth of this segment
8.4 Research institutes and academics
8.4.1 Rising prevalence of cancer and increasing research funding to drive the growth of this segment
8.5 Other end users

9 Cell Culture Media Market, by Region

10 Competitive Landscape
10.1 Overview
10.2 Key Player Strategies/Right to Win
10.3 Market Share Analysis
10.4 Major Market Players Revenue Share Analysis
10.5 Business Rating Quadrant
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Ubiquitous Players
10.5.4 Participants
10.6 Business Assessment Quadrant: Startups/SMEs
10.6.1 Progressive companies
10.6.2 Starting Blocks
10.6.3 Sensitive companies
10.6.4 Dynamic companies
10.7 Company Product Footprint
10.8 Regional footprint of companies
10.9 Competitive Scenario

11 company profiles
11.1 Key Players
11.1.1 Thermo Fisher Scientific, Inc.
11.1.2 Merck KGaA
11.1.3 Danaher Corporation
11.1.4 Sartorius AG
11.1.5 Corning Incorporated
11.1.6 Fujifilm Irvine Scientific, Inc. (acquired by Fujifilm Holdings Corporation)
11.1.7 Lonza Group Ag
11.1.8 Becton, Dickinson and company (Bd)
11.1.9 Miltenyi Biotec
11.1.10 Himedia Laboratories Pvt. ltd.
11.1.11 Stemcell Technologies Inc.
11.1.12 Biologos LLC.
11.2 Other Players
11.2.1 Cell Applications, Inc.
11.2.2 Caisson Laboratories Inc.
11.2.3 Promocell GmbH
11.2.4 Cell Biologics, Inc.
11.2.5 Invivogen
11.2.6 Pan Biotech GmbH
11.2.7 Peprotech, Inc.
11.2.8 Cellular Technology Limited LLC.
11.2.9 Zen-Bio, Inc.
11.2.10 Athena Environmental Sciences, Inc.
11.2.11 Cyagen Biosciences
11.2.12 Biowest SAS
11.2.13 Akron Biotech

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/a7i98h

  • Global Cell Culture Media Market


        


Source link

Previous Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2030 - ChattTenn Sports
Next We tried the new Wetherspoons menu and the KFC style chicken basket is finger licking good